Hershey Trust CO Voyager Therapeutics, Inc. Transaction History

Hershey Trust CO

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$6.0 - $10.78 $75,480 - $135,612	12,580 New	12,580 $96,000
Q2 2019 Aug 08, 2019	SELL	$19.18 - $27.88 $521,504 - $758,057	-27,190 Closed	0 $0
Q3 2018 Oct 29, 2018	BUY	$17.11 - $21.74 $216,373 - $274,924	12,646 Added 86.95%	27,190 $514,000
Q2 2018 Jul 26, 2018	BUY	$16.76 - $23.92 $243,757 - $347,892	14,544 New	14,544 $284,000

130

34.7M

39.7K

34.6K

Ticker VYGR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,647,600
Market Cap $218M
Description
Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyo...

Get notified when there are updates to the investment portfolio of Hershey Trust CO, based on Form 13F filings with the SEC.

Stay updated on Hershey Trust CO with notifications on news.